340B State Legislation: Week of April 26

The Tennessee General Assembly continues to consider legislation to prohibit discriminatory reimbursement in the 340B program. Learn more about the status of the bills in the final weeks of the legislative session by reading the newest TPCA blog post: 
Two bills in the Tennessee General Assembly to prohibit discriminatory reimbursement in the 340B drug pricing program are moving through the legislative process.  
SB1205/HB1348, sponsored by Senator Briggs and Representative Helton, will prohibit Pharmacy Benefit Managers (PBMs) and other third parties from engaging in discriminatory reimbursement. 
  • On Monday, March 29, HB1348 passed the full House on an 89-0 vote.  
  • On March 30, SB1205 passed the Senate Commerce & Labor Committee and was sent to the Senate Calendar Committee.   
SB1617/HB1398, sponsored by Senator Reeves and Representative Helton, contains the language of SB1205/HB1348, along with additional provisions related to PBMs.  
  • On Tuesday, April 21, HB1398 was heard in the House Finance, Ways, and Means Subcommittee and placed behind the budget. This mean no further action will occur on the bill until the budget has been approved. 
  • SB1617 will be heard in the Senate Finance, Ways, and Means Committee on Wednesday, April 28.  
You can stay up-to-date on the Tennessee General Assembly calendars and tune in live to the committee hearings by visiting the Tennessee General Assembly website. 

Review Schedules and Calendars >>> 



Upcoming Events

View All Events